Hyaluronidase (Vitrase) - ISTA
Alternative Names: Hyaluronidase - ISTA Pharmaceuticals; Ovine hyaluronidase - ISTA; Vitragan; VitraseLatest Information Update: 03 Dec 2021
At a glance
- Originator ISTA Pharmaceuticals
- Class Antineoplastics; Glycoside hydrolases; Polysaccharide lyases
- Mechanism of Action Hyaluronic acid modulators; Hyaluronidase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal Vitreous haemorrhage
- Discontinued Diabetic retinopathy
Most Recent Events
- 05 Aug 2013 Bausch & Lomb has been acquired by Valeant Pharmaceuticals International
- 06 Jun 2012 ISTA Pharmaceuticals has been acquired by Bausch & Lomb
- 30 Sep 2005 Preregistration for Vitreous haemorrhage in European Union (Ophthalmic)